Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Correlation Analysis of Organic Acid Comprehensive Profile Markers with Chemotherapy Induced Peripheral Neuropathy in Cancer Patients

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2017, v.38 no.1, pp.72-80
https://doi.org/10.13048/jkm.17007




  • Downloaded
  • Viewed

Abstract

Objectives: The purpose of this study is to evaluate the urinary organic acid comprehensive profile for chemotherapy induced peripheral neuropathy (CIPN). Methods: Participants are 66 patients with CIPN who had symptom (Visual analog scale ≥ 30 mm, Eastern Cooperative Oncology Group ≤ 2). Participants were tested with organic acid comprehensive profile markers. Results: Positive Correlation was observed in the neurotransmitter metabolism markers, N-methyl-D-aspartate (NMDA) modulators markers, detoxification markers, energy production markers, amino acid metabolism markers, and intestinal dysbiosis markers. Especially, all the neurotransmitter metabolism markers were showed positive rate of 44%. In addition, neuro-endo-immune was associated with energy metabolism (mitochondrial dysfunction) in CIPN of cancer patient. especially detoxification, intestinal bacterial hyperplasia, vitamin deficiency (folate, complex B group, vitamin C). Conclusions: Significant urinary organic acid comprehensive profile results were obtained in cancer patients who induced peripheral neuropathy by chemotherapy.

keywords
Chemotherapy induced peripheral neuropathy, Urinary organic acid, Neurotransmitter metabolism, Bio markers


Reference

1

1. Choie MH, Jeong IS, Jeong TY, Kim KS, Yoo HS. Effects of reflexology foot massage to improve quality of life and reduce anxiety for hospitalized cancer patients undergoing chemotherapy or radioisotope therapy. J Korean Trad Oncol. 2009;14:61-74.

2

2. Windebank AJ, Grisold W. Chemotherapy -induced neuropathy. J Peripher Nerv Syst. 2008;13(1):27-46.

3

3. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. European journal of cancer. 2008;44(11):1507-15.

4

4. Housheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Emin Oncol. 2006; 33; 15-49.

5

5. Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest. 1990;8:147–59.

6

6. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207–14.

7

7. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.

8

8. Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C, et al. Multi-center assessment of he Total Neuropathy Score for chemotherapy-induced peripheral eurotoxicity. J Peripher Nerv Syst. 2006;11:135-41.

9

9. Kwak MK, Kim EJ, Lee ER, Kwon IG, Hwang MS. Characteristics and Quality of Life in Patients with Chemotherapy-Induced Peripheral Neuropathy. Journal of Korean oncology nursing. 2010;10(2):231-9.

10

10. Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, et al. Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy. Eur J Cancer. 1997;33(9):1393-9.

11

11. Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM, et al. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol. 1997;35(1):47-53.

12

12. Du Bois A, Schlaich M, Luck HJ, Mollenkopf A, Wechsel U, Rauchholz M, et al. Evaluation of neurotoxicity induced by paclitaxel second -line chemotherapy. Support Care Cancer. 1999;7(5):354-61.

13

13. Kim JH, Choi KS, Kim TW, Hong YS. Quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy. Asian Oncology Nursing. 2011;11(3):254-62.

14

14. Kim HY, Kang JH, Youn HJ, So HS, Song CE, Chae SY, et al. Reliability and validty of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to assess chemotherapy -induced peripheral neuropathy. J Korean Acad Nurs. 2014;44(6):735-42.

15

15. Tofthagen CS, McMillan SC, Kip KE. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool. Cancer Nurs. 2011;34(4):E10-20.

16

16. Usha KM, Jayantee K, Pradeep PN. Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol. 2008;11(2):89-97.

17

17. Available at: URL: http://www.questdiagnostics. com/testcenter/testguide.action?dc=WP_LabDiag nosis_Peri pheralNeurop#Immune Mediated Peripheral Neuropathies.

18

18. Thomas N. Seyfried, Roberto E. Flores, Angela M. Poff, Dominic P.D’Agostino. Cancer as a Metabolic Disease. Carcinogenesis. 2014;35(3):515-27.

19

19. Lord RS, Bralley JA. Laboratory evaluations for integrative and functional medicine. Duluth. GA:Metametrix Institute. 2008.

20

20. Orgacka h, Zbytniewski Z. Excretion of vanillic acid and homovanillic acid and tissue distribution of catecholamines and their metabolites in mice with various levels of pigmentation. Endocrinol Pol. 1991;42(3):471-9.

상단으로 이동

Journal of Korean Medicine